Brief: Huakang Biomedical Sees A Loss Attributable Of About Rmb2.3 Million For Nine Months
Oct 28 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* HUAKANG BIOMEDICAL HOLDINGS CO LTD SEES A LOSS
ATTRIBUTABLE OF
ABOUT RMB2.3 MILLION FOR NINE MONTHS
* EXPECTED RESULT DUE TO SIGNIFICANT INCREASE IN GROUP'S
GROSS
PROFIT
Source text for Eikon: ID:
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology